
Todd M. DuChene, 62, has served as Executive Vice President, Chief Legal and Administrative Officer and Secretary at Core Scientific since May 2023. He became Corporate Secretary in April 2019 and progressed through multiple leadership roles including President and Chief Legal and Administrative Officer (November 2022-May 2023) and EVP, General Counsel and Chief Compliance Officer (January-November 2022). Prior to joining Core Scientific, he served as General Counsel and Corporate Secretary of Legacy Core from April 2019 through January 2022.
DuChene accumulated substantial general counsel experience at large technology and industrial companies. He served as Senior Vice President, General Counsel and Secretary and Chief Compliance Officer at FLIR Systems, Inc. (industrial and military technology) from September 2014 to April 2019. Previously, he was Executive Vice President, General Counsel and Secretary at Nuance Communications, Inc. (October 2011-September 2014), a leading speech recognition technology provider to enterprise, healthcare, and consumer markets. He held the role of Senior Vice President, General Counsel and Secretary at National Semiconductor Corporation from January 2008 to October 2011, prior to its acquisition by Texas Instruments. Earlier, he served as General Counsel at Solectron Corporation, Fisher Scientific International Inc. (now ThermoFisher Scientific), and OfficeMax, Inc.
DuChene holds a B.A. in Political Science from The College of Wooster and a J.D. from the University of Michigan Law School. He began his legal career as an associate at BakerHostetler law firm in Cleveland, Ohio in 1988.
Biography extracted from Core Scientific DEF 14A filed 2026-03-31 View cached copy (2026-08-31)Live source ↗
Photo: www.corescientific.com (Core Scientific official site) · retrieved 2026-08-31 · cached copy · match confidence high
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | See remarks | 2026-04 → present (5mo) | 21 |
Show 21 underlying filings | |||
Compensation
| Year | Role as filed | Salary | Bonus | Stock awards | Incentive | Other | Total | Source |
|---|---|---|---|---|---|---|---|---|
| 2025 | Executive Vice President, Chief Legal and Administrative Officer | $523.8K | — | $5.85M | $1.05M | — | $7.42M | View cached copy (2026-08-31)Live source ↗ |
| 2024 | Executive Vice President, Chief Legal and Administrative Officer | $500.0K | $150.0K | $13.90M | $875.0K | — | $15.43M | View cached copy (2026-08-31)Live source ↗ |
| 2023 | Executive Vice President, Chief Legal and Administrative Officer | $492.3K | — | — | — | $100 | $492.4K | View cached copy (2026-08-31)Live source ↗ |
| 2022 | Executive Vice President, Chief Legal and Administrative Officer, and Secretary | $300.8K | $375.0K | $3.85M | — | — | $4.53M | View cached copy (2026-08-31)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 138,547 | $0 | 220,999 | $5.00M | ↓ Divested $5.00M | 40 | $2.48M | $3.95M |
| 2026 | 138,547 | $0 | 220,999 | $5.00M | ↓ Divested $5.00M | 40 | $2.48M | $3.95M |
| 2026-Q2 | 138,547 | $0 | 105,469 | $2.67M | ↓ Divested $2.67M | 22 | $2.48M | $1.89M |
| 2026-Q3 | - | $0 | 115,530 | $2.33M | ↓ Divested $2.33M | 18 | $0 | $2.07M |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-09-04); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-08-31 | Core Scientific | Open-market sale | 10,000 | $162,340 | $178.9K |
| 2026-08-31 | Core Scientific | Open-market sale | 10,000 | $162,340 | $178.9K |
| 2026-08-24 | Core Scientific | Open-market sale | 10,000 | $174,493 | $178.9K |
| 2026-08-17 | Core Scientific | Open-market sale | 10,000 | $200,974 | $178.9K |
| 2026-08-17 | Core Scientific | Tax withholding on vesting | 11,205 | $225,557 | $200.5K |
| 2026-08-10 | Core Scientific | Open-market sale | 9,000 | $179,087 | $161.0K |
| 2026-08-10 | Core Scientific | Open-market sale | 1,000 | $20,648 | $17.9K |
| 2026-08-03 | Core Scientific | Open-market sale | 7,500 | $169,624 | $134.2K |
| 2026-08-03 | Core Scientific | Open-market sale | 1,500 | $32,325 | $26.8K |
| 2026-08-03 | Core Scientific | Open-market sale | 1,000 | $20,390 | $17.9K |
| 2026-07-27 | Core Scientific | Open-market sale | 100 | $2,249 | $1.8K |
| 2026-07-27 | Core Scientific | Open-market sale | 8,300 | $172,199 | $148.5K |
| 2026-07-27 | Core Scientific | Open-market sale | 1,600 | $35,028 | $28.6K |
| 2026-07-20 | Core Scientific | Open-market sale | 10,000 | $222,995 | $178.9K |
| 2026-07-16 | Core Scientific | Tax withholding on vesting | 4,325 | $98,264 | $77.4K |
| 2026-07-13 | Core Scientific | Open-market sale | 9,700 | $217,572 | $173.5K |
| 2026-07-13 | Core Scientific | Open-market sale | 300 | $6,903 | $5.4K |
| 2026-07-06 | Core Scientific | Open-market sale | 10,000 | $226,254 | $178.9K |
| 2026-06-30 | Core Scientific | Tax withholding on vesting | 5,469 | $139,952 | $97.8K |
| 2026-06-29 | Core Scientific | Open-market sale | 1,100 | $30,162 | $19.7K |
Show older transactions (20 more)
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-06-29 | Core Scientific | Open-market sale | 100 | $2,795 | $1.8K |
| 2026-06-29 | Core Scientific | Open-market sale | 8,800 | $228,701 | $157.4K |
| 2026-06-22 | Core Scientific | Open-market sale | 2,400 | $71,701 | $42.9K |
| 2026-06-22 | Core Scientific | Open-market sale | 7,600 | $221,238 | $136.0K |
| 2026-06-15 | Core Scientific | Open-market sale | 9,900 | $279,056 | $177.1K |
| 2026-06-15 | Core Scientific | Open-market sale | 100 | $2,879 | $1.8K |
| 2026-06-08 | Core Scientific | Open-market sale | 5,500 | $146,507 | $98.4K |
| 2026-06-08 | Core Scientific | Open-market sale | 4,500 | $121,974 | $80.5K |
| 2026-06-01 | Core Scientific | Open-market sale | 5,500 | $158,159 | $98.4K |
| 2026-06-01 | Core Scientific | Open-market sale | 1,300 | $35,007 | $23.3K |
| 2026-06-01 | Core Scientific | Open-market sale | 3,200 | $90,453 | $57.2K |
| 2026-05-26 | Core Scientific | Open-market sale | 10,000 | $262,540 | $178.9K |
| 2026-05-20 | Core Scientific | Grant / award / vesting | 138,547 | - | $2.48M |
| 2026-05-18 | Core Scientific | Open-market sale | 9,600 | $221,994 | $171.7K |
| 2026-05-18 | Core Scientific | Open-market sale | 400 | $9,503 | $7.2K |
| 2026-05-11 | Core Scientific | Open-market sale | 7,400 | $173,098 | $132.4K |
| 2026-05-11 | Core Scientific | Open-market sale | 2,600 | $59,322 | $46.5K |
| 2026-05-04 | Core Scientific | Open-market sale | 9,900 | $206,414 | $177.1K |
| 2026-05-04 | Core Scientific | Open-market sale | 100 | $2,153 | $1.8K |
| 2026-04-27 | Core Scientific | Open-market sale | 10,000 | $209,390 | $178.9K |
